Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Deep segmentation networks predict survival of non-small cell lung cancer.

Baek S, He Y, Allen BG, Buatti JM, Smith BJ, Tong L, Sun Z, Wu J, Diehn M, Loo BW, Plichta KA, Seyedin SN, Gannon M, Cabel KR, Kim Y, Wu X.

Sci Rep. 2019 Nov 21;9(1):17286. doi: 10.1038/s41598-019-53461-2.

2.

Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.

Anderson CM, Lee CM, Saunders DP, Curtis A, Dunlap N, Nangia C, Lee AS, Gordon SM, Kovoor P, Arevalo-Araujo R, Bar-Ad V, Peddada A, Colvett K, Miller D, Jain AK, Wheeler J, Blakaj D, Bonomi M, Agarwala SS, Garg M, Worden F, Holmlund J, Brill JM, Downs M, Sonis ST, Katz S, Buatti JM.

J Clin Oncol. 2019 Dec 1;37(34):3256-3265. doi: 10.1200/JCO.19.01507. Epub 2019 Oct 16.

PMID:
31618127
3.

First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.

Allen BG, Bodeker KL, Smith MC, Monga V, Sandhu S, Hohl R, Carlisle T, Brown H, Hollenbeck N, Vollstedt S, Greenlee JD, Howard MA, Mapuskar KA, Seyedin SN, Caster JM, Jones KA, Cullen JJ, Berg D, Wagner BA, Buettner GR, TenNapel MJ, Smith BJ, Spitz DR, Buatti JM.

Clin Cancer Res. 2019 Nov 15;25(22):6590-6597. doi: 10.1158/1078-0432.CCR-19-0594. Epub 2019 Aug 19.

PMID:
31427282
4.

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Clin Transl Radiat Oncol. 2019 Jun 27;18:39-45. doi: 10.1016/j.ctro.2019.06.007. eCollection 2019 Sep.

5.

Machine learning with the TCGA-HNSC dataset: improving usability by addressing inconsistency, sparsity, and high-dimensionality.

Rendleman MC, Buatti JM, Braun TA, Smith BJ, Nwakama C, Beichel RR, Brown B, Casavant TL.

BMC Bioinformatics. 2019 Jun 17;20(1):339. doi: 10.1186/s12859-019-2929-8.

6.

FDG PET based prediction of response in head and neck cancer treatment: Assessment of new quantitative imaging features.

Beichel RR, Ulrich EJ, Smith BJ, Bauer C, Brown B, Casavant T, Sunderland JJ, Graham MM, Buatti JM.

PLoS One. 2019 Apr 19;14(4):e0215465. doi: 10.1371/journal.pone.0215465. eCollection 2019.

7.

Training Requirements for Theranostics: A Unique Opportunity for Collaboration.

Graham MM, Buatti JM.

J Nucl Med. 2019 Sep;60(9):1205-1206. doi: 10.2967/jnumed.119.228940. Epub 2019 Apr 6. No abstract available.

PMID:
30954946
8.

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Transl Res. 2019 Jun;208:63-72. doi: 10.1016/j.trsl.2019.02.011. Epub 2019 Feb 27.

PMID:
30885538
9.

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer.

Ulrich EJ, Menda Y, Boles Ponto LL, Anderson CM, Smith BJ, Sunderland JJ, Graham MM, Buatti JM, Beichel RR.

Tomography. 2019 Mar;5(1):161-169. doi: 10.18383/j.tom.2018.00038.

10.

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Neuro Oncol. 2018 Nov 12;20(12):1652-1660. doi: 10.1093/neuonc/noy099.

11.

Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer.

Alexander MS, Wilkes JG, Schroeder SR, Buettner GR, Wagner BA, Du J, Gibson-Corley K, O'Leary BR, Spitz DR, Buatti JM, Berg DJ, Bodeker KL, Vollstedt S, Brown HA, Allen BG, Cullen JJ.

Cancer Res. 2018 Dec 15;78(24):6838-6851. doi: 10.1158/0008-5472.CAN-18-1680. Epub 2018 Sep 25.

12.

Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas.

Guram K, Smith M, Ginader T, Bodeker K, Pelland D, Pennington E, Buatti JM.

Pract Radiat Oncol. 2019 Jan;9(1):16-23. doi: 10.1016/j.prro.2018.06.001. Epub 2018 Jun 5.

PMID:
30195927
13.

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):845-853. doi: 10.1016/j.ijrobp.2018.04.006. Epub 2018 Apr 12.

PMID:
29976497
14.

The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.

Press RH, Shu HG, Shim H, Mountz JM, Kurland BF, Wahl RL, Jones EF, Hylton NM, Gerstner ER, Nordstrom RJ, Henderson L, Kurdziel KA, Vikram B, Jacobs MA, Holdhoff M, Taylor E, Jaffray DA, Schwartz LH, Mankoff DA, Kinahan PE, Linden HM, Lambin P, Dilling TJ, Rubin DL, Hadjiiski L, Buatti JM.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1219-1235. doi: 10.1016/j.ijrobp.2018.06.023. Epub 2018 Jun 30. Review.

15.

SBRT to adrenal metastases provides high local control with minimal toxicity.

Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, Flynn RT, Bhatia SK, Smith MC, Buatti JM, Allen BG.

Adv Radiat Oncol. 2017 Aug 4;2(4):581-587. doi: 10.1016/j.adro.2017.07.011. eCollection 2017 Oct-Dec.

16.

Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.

Anderson CM, Sonis ST, Lee CM, Adkins D, Allen BG, Sun W, Agarwala SS, Venigalla ML, Chen Y, Zhen W, Mould DR, Holmlund JT, Brill JM, Buatti JM.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):427-435. doi: 10.1016/j.ijrobp.2017.10.019. Epub 2017 Oct 16.

17.

Automated model-based quantitative analysis of phantoms with spherical inserts in FDG PET scans.

Ulrich EJ, Sunderland JJ, Smith BJ, Mohiuddin I, Parkhurst J, Plichta KA, Buatti JM, Beichel RR.

Med Phys. 2018 Jan;45(1):258-276. doi: 10.1002/mp.12643. Epub 2017 Nov 23.

18.

Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone.

Seyedin SN, Mitchell DL, Mott SL, Russo JK, Tracy CR, Snow AN, Parkhurst JR, Smith MC, Buatti JM, Watkins JM.

Pathol Oncol Res. 2019 Jan;25(1):209-215. doi: 10.1007/s12253-017-0349-5. Epub 2017 Oct 27.

PMID:
29079967
19.

Development of a radiobiological evaluation tool to assess the expected clinical impacts of contouring accuracy between manual and semi-automated segmentation algorithms.

Yusung Kim, Patwardhan KA, Beichel RR, Smith BJ, Mart C, Plichta KA, Chang T, Sonka M, Graham MM, Magnotta V, Casavant T, Junyi Xia, Buatti JM.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3409-3412. doi: 10.1109/EMBC.2017.8037588.

PMID:
29060629
20.

Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.

Andresen NS, Buatti JM, Tewfik HH, Pagedar NA, Anderson CM, Watkins JM.

Eur Thyroid J. 2017 Jul;6(4):187-196. doi: 10.1159/000468927. Epub 2017 Mar 23. Review.

21.

O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Kauffman EPS, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG.

Cancer Cell. 2017 Aug 14;32(2):268. doi: 10.1016/j.ccell.2017.07.008. No abstract available.

22.

Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy.

Mapuskar KA, Flippo KH, Schoenfeld JD, Riley DP, Strack S, Hejleh TA, Furqan M, Monga V, Domann FE, Buatti JM, Goswami PC, Spitz DR, Allen BG.

Cancer Res. 2017 Sep 15;77(18):5054-5067. doi: 10.1158/0008-5472.CAN-17-0106. Epub 2017 Aug 1.

23.

Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials.

Zahra A, Fath MA, Opat E, Mapuskar KA, Bhatia SK, Ma DC, Rodman SN III, Snyders TP, Chenard CA, Eichenberger-Gilmore JM, Bodeker KL, Ahmann L, Smith BJ, Vollstedt SA, Brown HA, Hejleh TA, Clamon GH, Berg DJ, Szweda LI, Spitz DR, Buatti JM, Allen BG.

Radiat Res. 2017 Jun;187(6):743-754. doi: 10.1667/RR14668.1. Epub 2017 Apr 24.

24.

O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Shanahan Kauffman EP, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG.

Cancer Cell. 2017 Apr 10;31(4):487-500.e8. doi: 10.1016/j.ccell.2017.02.018. Epub 2017 Mar 30. Erratum in: Cancer Cell. 2017 Aug 14;32(2):268.

25.

Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.

Beichel RR, Smith BJ, Bauer C, Ulrich EJ, Ahmadvand P, Budzevich MM, Gillies RJ, Goldgof D, Grkovski M, Hamarneh G, Huang Q, Kinahan PE, Laymon CM, Mountz JM, Muzi JP, Muzi M, Nehmeh S, Oborski MJ, Tan Y, Zhao B, Sunderland JJ, Buatti JM.

Med Phys. 2017 Feb;44(2):479-496. doi: 10.1002/mp.12041.

26.

Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) Survey.

Kurland BF, Aggarwal S, Yankeelov TE, Gerstner ER, Mountz JM, Linden HM, Jones EF, Bodeker KL, Buatti JM.

Tomography. 2016 Dec;2(4):276-282. doi: 10.18383/j.tom.2016.00169.

27.

A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy.

Mohiuddin IH, Furqan M, Clamon G, Keech J, Anderson C, Smith MC, Buatti JM, Allen BG.

Ann Radiat Ther Oncol. 2017;1(3). pii: 1011. Epub 2017 Nov 22.

28.

Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer.

Zahra A, Chang T, Hejleh TA, Furqan M, Clamon GH, Bhatia SK, Watkins JM, Mott SL, Ahmann LL, Bodeker KL, Spitz DR, Buatti JM, Allen BG.

J Oncol Transl Res. 2016 Nov;2(1). pii: 108. Epub 2016 Jul 26.

29.

Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival.

Kaelberer JB, O'Donnell MA, Mitchell DL, Snow AN, Mott SL, Buatti JM, Smith MC, Watkins JM.

Prostate Int. 2016 Sep;4(3):107-12. doi: 10.1016/j.prnil.2016.06.002. Epub 2016 Jun 23.

30.

Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis.

Watkins JM, Mitchell DL, Russo JK, Mott SL, Tracy CR, Smith MC, Buatti JM.

Clin Genitourin Cancer. 2017 Apr;15(2):242-247. doi: 10.1016/j.clgc.2016.05.016. Epub 2016 May 29.

PMID:
27338519
31.

Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.

McGuire SM, Bhatia SK, Sun W, Jacobson GM, Menda Y, Ponto LL, Smith BJ, Gross BA, Bayouth JE, Sunderland JJ, Graham MM, Buatti JM.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):228-39. doi: 10.1016/j.ijrobp.2016.04.009. Epub 2016 Apr 19.

32.

Semiautomated segmentation of head and neck cancers in 18F-FDG PET scans: A just-enough-interaction approach.

Beichel RR, Van Tol M, Ulrich EJ, Bauer C, Chang T, Plichta KA, Smith BJ, Sunderland JJ, Graham MM, Sonka M, Buatti JM.

Med Phys. 2016 Jun;43(6):2948-2964. doi: 10.1118/1.4948679.

33.

Quantitative Imaging in Cancer Clinical Trials.

Yankeelov TE, Mankoff DA, Schwartz LH, Lieberman FS, Buatti JM, Mountz JM, Erickson BJ, Fennessy FM, Huang W, Kalpathy-Cramer J, Wahl RL, Linden HM, Kinahan PE, Zhao B, Hylton NM, Gillies RJ, Clarke L, Nordstrom R, Rubin DL.

Clin Cancer Res. 2016 Jan 15;22(2):284-90. doi: 10.1158/1078-0432.CCR-14-3336. Review.

34.

Paddle-based rotating-shield brachytherapy.

Liu Y, Flynn RT, Kim Y, Dadkhah H, Bhatia SK, Buatti JM, Xu W, Wu X.

Med Phys. 2015 Oct;42(10):5992-6003. doi: 10.1118/1.4930807.

35.

Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions.

Mitchell DL, Tracy CR, Buatti JM, Smith MC, Snow AN, Henry MD, Vaena DA, Tewfik HH, Watkins JM.

Clin Genitourin Cancer. 2016 Feb;14(1):12-21. doi: 10.1016/j.clgc.2015.07.022. Epub 2015 Aug 6. Review.

PMID:
26341039
36.

Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.

Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):472-9. doi: 10.1016/j.ijrobp.2014.11.002. Epub 2015 Jan 30.

37.

Disease outcomes for skull base and spinal chordomas: a single center experience.

Ahmed R, Sheybani A, Menezes AH, Buatti JM, Hitchon PW.

Clin Neurol Neurosurg. 2015 Mar;130:67-73. doi: 10.1016/j.clineuro.2014.12.015. Epub 2014 Dec 29.

PMID:
25590662
38.

Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-PET, and MR Images of Head and Neck Cancer.

Anderson CM, Sun W, Buatti JM, Maley JE, Policeni B, Mott SL, Bayouth JE.

Jacobs J Radiat Oncol. 2014 Sep;1(1):006.

39.

Impact of spot size on plan quality of spot scanning proton radiosurgery for peripheral brain lesions.

Wang D, Dirksen B, Hyer DE, Buatti JM, Sheybani A, Dinges E, Felderman N, TenNapel M, Bayouth JE, Flynn RT.

Med Phys. 2014 Dec;41(12):121705. doi: 10.1118/1.4901260.

PMID:
25471952
40.

Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism.

Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, Schoenfeld JD, Buatti JM, Spitz DR, Fath MA.

Redox Biol. 2014;2:963-70. doi: 10.1016/j.redox.2014.08.002. Epub 2014 Aug 7. Review.

41.

An Almost Linear Time Algorithm for Field Splitting in Radiation Therapy.

Wu X, Dou X, Bayouth JE, Buatti JM.

Comput Geom. 2013 Aug 1;46(6):673-687.

42.

3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.

Muruganandham M, Clerkin PP, Smith BJ, Anderson CM, Morris A, Capizzano AA, Magnotta V, McGuire SM, Smith MC, Bayouth JE, Buatti JM.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):181-9. doi: 10.1016/j.ijrobp.2014.05.014. Epub 2014 Jun 28.

43.

ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.

Expert Panel on Radiation Oncology-Brain Metastases, Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, Henderson MA, Murad GJ, Patchell RA, Patel SH, Robbins JR, Robins HI, Vassil AD, Wippold FJ 2nd, Yunes MJ, Videtic GM.

J Palliat Med. 2014 Aug;17(8):880-6. doi: 10.1089/jpm.2014.9417. Epub 2014 Jun 27. Review.

44.

Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.

Mountz JM, Yankeelov TE, Rubin DL, Buatti JM, Erikson BJ, Fennessy FM, Gillies RJ, Huang W, Jacobs MA, Kinahan PE, Laymon CM, Linden HM, Mankoff DA, Schwartz LH, Shim H, Wahl RL.

J Clin Oncol. 2014 Jul 1;32(19):2115-6. doi: 10.1200/JCO.2014.55.8866. Epub 2014 May 27. No abstract available.

45.

Response to "where do patients with cancer in Iowa receive radiation therapy?".

Anderson C, Buatti JM.

J Oncol Pract. 2014 Jul;10(4):e283. doi: 10.1200/JOP.2014.001425. Epub 2014 May 13. No abstract available.

PMID:
24824540
46.

The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Ryken TC, Kalkanis SN, Buatti JM, Olson JJ; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):479-88. doi: 10.1007/s11060-013-1336-7. Epub 2014 Apr 23. Review.

PMID:
24756348
47.

The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Ryu S, Buatti JM, Morris A, Kalkanis SN, Ryken TC, Olson JJ; AANS/CNS Joint Guidelines Committee.

J Neurooncol. 2014 Jul;118(3):489-99. doi: 10.1007/s11060-013-1337-6. Epub 2014 Apr 12. Review.

PMID:
24728785
48.

Parathyroid adenoma: report of a patient successfully treated with stereotactic body radiation therapy.

Parkhurst J, Erickson S, Sun W, Funk G, Anderson C, Buatti JM.

Pract Radiat Oncol. 2014 Jan-Feb;4(1):55-7. doi: 10.1016/j.prro.2013.10.008. Epub 2013 Dec 5. No abstract available.

PMID:
24621424
49.

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.

Hoover AC, Milhem MM, Anderson CM, Sun W, Smith BJ, Hoffman HT, Buatti JM.

Head Neck. 2015 May;37(5):722-6. doi: 10.1002/hed.23664. Epub 2014 Jun 18.

50.

Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts.

Allen BG, Bhatia SK, Buatti JM, Brandt KE, Lindholm KE, Button AM, Szweda LI, Smith BJ, Spitz DR, Fath MA.

Clin Cancer Res. 2013 Jul 15;19(14):3905-13. doi: 10.1158/1078-0432.CCR-12-0287. Epub 2013 Jun 6.

Supplemental Content

Loading ...
Support Center